These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1347417)

  • 41. c-erbB-2 amplification and overexpression in breast cancer: evaluation and comparison of Southern blot, slot blot, ELISA and immunohistochemistry.
    Dawkins HJ; Robbins PD; Sarna M; Carrello S; Harvey JM; Sterrett GF
    Pathology; 1993 Apr; 25(2):124-32. PubMed ID: 8103591
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Overexpression of the c-erbB-2 protein in human breast tumor cell lines.
    Hynes NE; Gerber HA; Saurer S; Groner B
    J Cell Biochem; 1989 Feb; 39(2):167-73. PubMed ID: 2565909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Critical determination of the frequency of c-erbB-2 amplification in breast cancer.
    Hubbard AL; Doris CP; Thompson AM; Chetty U; Anderson TJ
    Br J Cancer; 1994 Sep; 70(3):434-9. PubMed ID: 7915911
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Detection of HER-2 oncogene amplification in breast cancer by differential polymerase chain reaction from single cryosections.
    Friedrichs K; Lohmann D; Höfler H
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1993; 64(4):209-12. PubMed ID: 7904515
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.
    Slamon DJ; Godolphin W; Jones LA; Holt JA; Wong SG; Keith DE; Levin WJ; Stuart SG; Udove J; Ullrich A
    Science; 1989 May; 244(4905):707-12. PubMed ID: 2470152
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Amplification of the neu (c-erbB-2) oncogene in human mammmary tumors is relatively frequent and is often accompanied by amplification of the linked c-erbA oncogene.
    van de Vijver M; van de Bersselaar R; Devilee P; Cornelisse C; Peterse J; Nusse R
    Mol Cell Biol; 1987 May; 7(5):2019-23. PubMed ID: 3299059
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and pathologic significance of the c-erbB-2 (HER-2/neu) oncogene.
    Singleton TP; Strickler JG
    Pathol Annu; 1992; 27 Pt 1():165-90. PubMed ID: 1346551
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Her-2/neu expression in node-negative breast cancer: direct tissue quantitation by computerized image analysis and association of overexpression with increased risk of recurrent disease.
    Press MF; Pike MC; Chazin VR; Hung G; Udove JA; Markowicz M; Danyluk J; Godolphin W; Sliwkowski M; Akita R
    Cancer Res; 1993 Oct; 53(20):4960-70. PubMed ID: 8104689
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers: a role for hematopoietic growth factor release by tumor cells?
    Tang RP; Kacinski B; Validire P; Beuvon F; Sastre X; Benoit P; dela Rochefordière A; Mosseri V; Pouillart P; Scholl S
    J Cell Biochem; 1990 Nov; 44(3):189-98. PubMed ID: 1980125
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cellular and tumoural heterogeneity of EGFR gene amplification in human malignant gliomas.
    Strommer K; Hamou MF; Diggelmann H; de Tribolet N
    Acta Neurochir (Wien); 1990; 107(3-4):82-7. PubMed ID: 2077857
    [TBL] [Abstract][Full Text] [Related]  

  • 51. c-erbB-2 oncogene expression in hepatocellular carcinoma and cholangiocarcinoma.
    Collier JD; Guo K; Mathew J; May FE; Bennett MK; Corbett IP; Bassendine MF; Burt AD
    J Hepatol; 1992 Mar; 14(2-3):377-80. PubMed ID: 1380026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. c-erbB-2 oncogene related to p53 expression, cell proliferation and prognosis in breast cancer.
    Lipponen HJ; Aaltomaa S; Syrjänen S; Syrjänen K
    Anticancer Res; 1993; 13(4):1147-52. PubMed ID: 8102517
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Amplification of the c-erbB-2 gene in gastric carcinoma: correlation with survival.
    Tsugawa K; Fushida S; Yonemura Y
    Oncology; 1993; 50(6):418-25. PubMed ID: 7901825
    [TBL] [Abstract][Full Text] [Related]  

  • 54. C-erb B-2 amplification in cystic renal disease.
    Herrera GA
    Kidney Int; 1991 Sep; 40(3):509-13. PubMed ID: 1686289
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparative investigation of c-erbB2/neu expression in head and neck tumors and mammary cancer.
    Rivière A; Becker J; Löning T
    Cancer; 1991 Apr; 67(8):2142-9. PubMed ID: 1672262
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chromosome 11q13, c-erbB-2, and c-myc amplification in invasive breast carcinoma: clinicopathologic correlations.
    Gaffey MJ; Frierson HF; Williams ME
    Mod Pathol; 1993 Nov; 6(6):654-9. PubMed ID: 7905628
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Different assays for HER-2/neu evaluation in breast cancer.
    Tommasi S; Paradiso A; Serio G; Barletta A; Mangia A; Giannella C; De Lena M
    Tumori; 1992 Apr; 78(2):106-10. PubMed ID: 1355935
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Amplification of c-erbB-2 oncogene in human adenocarcinomas in vivo.
    Yokota J; Yamamoto T; Toyoshima K; Terada M; Sugimura T; Battifora H; Cline MJ
    Lancet; 1986 Apr; 1(8484):765-7. PubMed ID: 2870269
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Oncogene patterns in breast and ovarian carcinomas.
    Csókay B; Papp J; Besznyák I; Bösze P; Sárosi Z; Tóth J; Zalay Z; Oláh E
    Eur J Surg Oncol; 1993 Dec; 19(6):593-9. PubMed ID: 7903645
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of the erb B oncogene in the Morris hepatoma 7777.
    Hocher B; Abou-Rebyeh H; Plaum M; Fakhury M; Schiller S; Bauer C
    Eur J Clin Chem Clin Biochem; 1994 Sep; 32(9):697-704. PubMed ID: 7865626
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.